Cinnamon and Hop Extracts as Potential Immunomodulators for Severe COVID-19 Cases

doi:10.3389/fpls.2021.589783

. 2021 Feb 26:12:589783.

doi: 10.3389/fpls.2021.589783. eCollection 2021.

Cinnamon and Hop Extracts as Potential Immunomodulators for Severe COVID-19 Cases

Kurt Lucas¹, Janine Fröhlich-Nowoisky¹, Nicole Oppitz¹, Maximilian Ackermann^{2

3}

Affiliations

¹ Multiphase Chemistry Department, Max Planck Institute for Chemistry, Mainz, Germany.
² Institute of Pathology and Molecular Pathology, Helios University Clinic Wuppertal, University of Witten/Herdecke, Wuppertal, Germany.
³ Institute of Functional and Clinical Anatomy, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.

PMID: 33719281
PMCID: PMC7952639
DOI: 10.3389/fpls.2021.589783

Cinnamon and Hop Extracts as Potential Immunomodulators for Severe COVID-19 Cases

Kurt Lucas et al. Front Plant Sci. 2021.

. 2021 Feb 26:12:589783.

doi: 10.3389/fpls.2021.589783. eCollection 2021.

Authors

Kurt Lucas¹, Janine Fröhlich-Nowoisky¹, Nicole Oppitz¹, Maximilian Ackermann^{2

3}

Affiliations

¹ Multiphase Chemistry Department, Max Planck Institute for Chemistry, Mainz, Germany.
² Institute of Pathology and Molecular Pathology, Helios University Clinic Wuppertal, University of Witten/Herdecke, Wuppertal, Germany.
³ Institute of Functional and Clinical Anatomy, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.

PMID: 33719281
PMCID: PMC7952639
DOI: 10.3389/fpls.2021.589783

No abstract available

Keywords: COVID-19; Ceylon cinnamon; angiogenesis inhibition; anti-inflammatory (activity); hops.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Cited by

Strategies for the Management of Spike Protein-Related Pathology.
Halma MTJ, Plothe C, Marik P, Lawrie TA. Halma MTJ, et al. Microorganisms. 2023 May 17;11(5):1308. doi: 10.3390/microorganisms11051308. Microorganisms. 2023. PMID: 37317282 Free PMC article. Review.
Plants as Biofactories for Therapeutic Proteins and Antiviral Compounds to Combat COVID-19.
England C, TrejoMartinez J, PerezSanchez P, Karki U, Xu J. England C, et al. Life (Basel). 2023 Feb 23;13(3):617. doi: 10.3390/life13030617. Life (Basel). 2023. PMID: 36983772 Free PMC article. Review.
An Updated Review of the Genus Humulus: A Valuable Source of Bioactive Compounds for Health and Disease Prevention.
Carbone K, Gervasi F. Carbone K, et al. Plants (Basel). 2022 Dec 8;11(24):3434. doi: 10.3390/plants11243434. Plants (Basel). 2022. PMID: 36559547 Free PMC article. Review.
Overview of Antiviral Drug Therapy for COVID-19: Where Do We Stand?
Esposito R, Mirra D, Sportiello L, Spaziano G, D'Agostino B. Esposito R, et al. Biomedicines. 2022 Nov 4;10(11):2815. doi: 10.3390/biomedicines10112815. Biomedicines. 2022. PMID: 36359334 Free PMC article. Review.
Medicinal Herbs in the Relief of Neurological, Cardiovascular, and Respiratory Symptoms after COVID-19 Infection A Literature Review.
Nawrot J, Gornowicz-Porowska J, Budzianowski J, Nowak G, Schroeder G, Kurczewska J. Nawrot J, et al. Cells. 2022 Jun 11;11(12):1897. doi: 10.3390/cells11121897. Cells. 2022. PMID: 35741026 Free PMC article. Review.

See all "Cited by" articles

References

1. Ackermann M., Verleden S. E., Kuehnel M., Haverich A., Welte T., Laenger F., et al. . (2020). Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N. Engl. J. Med. 383, 120–128. 10.1056/NEJMoa2015432 - DOI - PMC - PubMed
1. Aghamiri V., Mirghafourvand M., Mohammad-Alizadeh-Charandabi S., Nazemiyeh H. (2016). The effect of Hop (Humulus lupulus L.) on early menopausal symptoms and hot flashes: a randomized placebo-controlled trial. Complement. Ther. Clin. Pract. 23, 130–135. 10.1016/j.ctcp.2015.05.001 - DOI - PubMed
1. Akilen R., Tsiami A., Devendra D., Robinson N. (2010). Glycated haemoglobin and blood pressure-lowering effect of cinnamon in multi-ethnic Type 2 diabetic patients in the UK: a randomized, placebo-controlled, double-blind clinical trial. Diabet. Med. 27, 1159–1167. 10.1111/j.1464-5491.2010.03079.x - DOI - PubMed
1. Altschuler J. A., Casella S. J., Mackenzie T. A., Curtis K. M. (2007). The effect of cinnamon on A1C among adolescents with type 1 diabetes. Diabetes Care 30, 813–816. 10.2337/dc06-1871 - DOI - PubMed
1. Askari F., Rashidkhani B., Hekmatdoost A. (2014). Cinnamon may have therapeutic benefits on lipid profile, liver enzymes, insulin resistance, and high-sensitivity C-reactive protein in nonalcoholic fatty liver disease patients. Nutr. Res. 34, 143–148. 10.1016/j.nutres.2013.11.005 - DOI - PubMed

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations

[1] Ackermann M., Verleden S. E., Kuehnel M., Haverich A., Welte T., Laenger F., et al. . (2020). Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N. Engl. J. Med. 383, 120–128. 10.1056/NEJMoa2015432 - DOI - PMC - PubMed

[2] Ackermann M., Verleden S. E., Kuehnel M., Haverich A., Welte T., Laenger F., et al. . (2020). Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N. Engl. J. Med. 383, 120–128. 10.1056/NEJMoa2015432 - DOI - PMC - PubMed

[3] Aghamiri V., Mirghafourvand M., Mohammad-Alizadeh-Charandabi S., Nazemiyeh H. (2016). The effect of Hop (Humulus lupulus L.) on early menopausal symptoms and hot flashes: a randomized placebo-controlled trial. Complement. Ther. Clin. Pract. 23, 130–135. 10.1016/j.ctcp.2015.05.001 - DOI - PubMed

[4] Aghamiri V., Mirghafourvand M., Mohammad-Alizadeh-Charandabi S., Nazemiyeh H. (2016). The effect of Hop (Humulus lupulus L.) on early menopausal symptoms and hot flashes: a randomized placebo-controlled trial. Complement. Ther. Clin. Pract. 23, 130–135. 10.1016/j.ctcp.2015.05.001 - DOI - PubMed

[5] Akilen R., Tsiami A., Devendra D., Robinson N. (2010). Glycated haemoglobin and blood pressure-lowering effect of cinnamon in multi-ethnic Type 2 diabetic patients in the UK: a randomized, placebo-controlled, double-blind clinical trial. Diabet. Med. 27, 1159–1167. 10.1111/j.1464-5491.2010.03079.x - DOI - PubMed

[6] Akilen R., Tsiami A., Devendra D., Robinson N. (2010). Glycated haemoglobin and blood pressure-lowering effect of cinnamon in multi-ethnic Type 2 diabetic patients in the UK: a randomized, placebo-controlled, double-blind clinical trial. Diabet. Med. 27, 1159–1167. 10.1111/j.1464-5491.2010.03079.x - DOI - PubMed

[7] Altschuler J. A., Casella S. J., Mackenzie T. A., Curtis K. M. (2007). The effect of cinnamon on A1C among adolescents with type 1 diabetes. Diabetes Care 30, 813–816. 10.2337/dc06-1871 - DOI - PubMed

[8] Altschuler J. A., Casella S. J., Mackenzie T. A., Curtis K. M. (2007). The effect of cinnamon on A1C among adolescents with type 1 diabetes. Diabetes Care 30, 813–816. 10.2337/dc06-1871 - DOI - PubMed

[9] Askari F., Rashidkhani B., Hekmatdoost A. (2014). Cinnamon may have therapeutic benefits on lipid profile, liver enzymes, insulin resistance, and high-sensitivity C-reactive protein in nonalcoholic fatty liver disease patients. Nutr. Res. 34, 143–148. 10.1016/j.nutres.2013.11.005 - DOI - PubMed

[10] Askari F., Rashidkhani B., Hekmatdoost A. (2014). Cinnamon may have therapeutic benefits on lipid profile, liver enzymes, insulin resistance, and high-sensitivity C-reactive protein in nonalcoholic fatty liver disease patients. Nutr. Res. 34, 143–148. 10.1016/j.nutres.2013.11.005 - DOI - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Cinnamon and Hop Extracts as Potential Immunomodulators for Severe COVID-19 Cases

Affiliations

Cinnamon and Hop Extracts as Potential Immunomodulators for Severe COVID-19 Cases

Authors

Affiliations

Conflict of interest statement

Similar articles

Cited by

References

LinkOut - more resources

Full Text Sources

Other Literature Sources